Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells

Molecules

Volumn 16, Issue 4, 2011, Pages 2944-2959

  Al Qubaisi, Mothanna ^a   Rozita, Rosli ^a   Yeap, Swee Keong ^a   Omar, Abdul Rahman ^a   Ali, Abdul Manaf ^b   Alitheen, Noorjahan B ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

Author keywords

Cytotoxicity; Goniothalamin; HepG2 cell; Liver chang cell

Indexed keywords

GONIOTHALAMIN; PYRONE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; FLOW CYTOMETRY; HEPATOBLASTOMA; HUMAN; IC 50; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HEPATOBLASTOMA; HUMANS; INHIBITORY CONCENTRATION 50; LIVER NEOPLASMS; MOLECULAR STRUCTURE; PYRONES;

EID: 79955539699     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16042944     Document Type: Article

References (23)

1. El-Serag, H.B.; Mason, A.C. Rising incidence of hepatocellular carcinoma in the United States. New. Engl. J. Med. 1999, 340, 745-750. (Pubitemid 29114292)
2. Kubicka, S.; Rudolph, K.L.; Hanke, M.; Tietze, M.K.; Tillmann, H.L.; Trautwein, C. Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area. Liver 2000, 20, 312-318. (Pubitemid 30488002)
3. Huang, C.C.; Wu, M.C.; Xu, G.W.; Li, D.Z.; Cheng, H.; Tu, Z.X.; Jiang, H.Q.; Gu, J.R. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J. Natl. Cancer Inst. 1992, 84, 262-264.
4. Honda, K.; Sbisa, E.; Tullo, A.; Papeo, P.A.; Saccone, C.; Poole, S.; Pignatelli, M.; Mitry, R.R.; Ding, S.; Isla, A.; Davies, A.; Habib, N.A. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br. J. Cancer 1998, 77, 776-782. (Pubitemid 28077466)
5. Heinze, T.; Jonas, S.; Karsten, A.; Neuhaus, P. Determination of the oncogenes p53 and C-Erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. Anticancer Res.1999, 19, 2501-2503. (Pubitemid 29392400)
6. Shah, S.R.; Riordan, S.M.; Karani, J.; Williams, R. Tumor ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma. QJM 1998, 91, 821-828. (Pubitemid 29027068)
7. Mehta, D.K. British National Formulary, 52nd ed.; Pharmaceutical Press: London, UK, 2006.
8. Sam, T.W.; Sew-Yeu, C.; Matsjeh, S.; Gan, E.K.; Razak, D.; Mohamed, A.L. Goniothalamin oxide: An embryotoxic compound from Goniothalamus macrophyllus (Annonaceae). Tetrahedron Lett. 1987, 28, 2541-2544.
9. Chatchai, W.; Boonsong, W.; Puttachat, S.; Arunporn, I.; Niwat, K. Goniothalamin, a cytotoxic compound, isolated from Goniothalamus macrophyllus (Blume) Hook. f. & Thomson var. macrophyllus. Songklanakarin. J. Sci. Technol. 2005, 27, 479-487.
10. Chen, W.Y.; Wu, C.C.; Lan, Y.H.; Chang, F.R.; Teng, C.M.; Wu, Y.C. Goniothalamin induces cell cycle-specific apoptosis by modulating the redox status in MDA-MB-231 cells. Eur. J. Pharmacol. 2005, 522, 20-29.
11. de Fátima, A.; Kohn, L.K.; Antônio, M.A.; de Carvalho, J.E.; Pilli, R.A. (R)- Goniothalamin: Total syntheses and cytotoxic activity against cancer cell lines. Bioorg. Med. Chem. 2005, 13, 2927-2933. (Pubitemid 40392478)
12. Newall, C.A.; Anderson, L.A.; Phillipson, J.D. Herbal Medicines. A Guide for Health-care Professionals; Pharmaceutical Press: London, UK, 1996.
13. Schulz, V.; Rudolf, H.; Tyler, V.E. Rational Phytotherapy. A Physician's Guide to Herbal Medicine, 3rd ed.; Springer: Berlin, Germany, 1998.
14. Adams, J. Proteasome inhibition in cancer: Development of PS-341. Sem. Oncol. 2001, 28, 613-619. (Pubitemid 33134421)
15. Pihie, A.H.; Stanslas, J.; Din, L.B. Non-steroid receptor mediated antiproliferative activity of styrylpyrone derivative (SPD) in human breast cancer cell lines. Anticancer Res. 1998, 18, 1739-1744.
16. Andreas, P.S.; Kerstin, M.; Patricia, G.; Gesine, B; Kirsten, V.; Michael, H.; Antje, K.; Bernhard, H.; Harald, S.; Rajan, S.; Detlef, S.; Martin, Z.; Hans, S. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. J. Hepatol. 2004, 41, 799-807.
17. Wahl, A.F.; Donaldson, K.L.; Fairchild, C.; Lee, F.Y.; Foster, S.A.; Demers, G.W.; Galloway, D.A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat. Med. 1996, 2, 72-79. (Pubitemid 26029571)
18. Lee, T.K.; Lau, T.C.; Ng, I.O. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother. Pharmacol. 2002, 49, 78-86. (Pubitemid 40826336)
19. Gratzner, H.G. Monoclonal antibody to 5-bromo- and 5- Iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982, 218, 474-475. (Pubitemid 12000901)
20. Chan, K.M.; Rajab, N.F.; Ishak, M.H.A.; Ali, A.M.; Yusoff, K.; Din, L.B.; Inayat-Hussain, S.H. Goniothalamin induces apoptosis in vascular smooth muscle cells. Chem. Biol. Interact. 2006, 159, 129-140. (Pubitemid 43042620)
21. Inayat-Hussain, S.H.; Annuar, B.O.; Din, L.B.; Ali, A.M.; Ross, D. Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by the novel styryllactone goniothalamin in HL-60 leukemia cells. Toxicol. In Vitro 2003, 17, 433-439. (Pubitemid 36776785)
22. Tay, N.; Chan, S.H.; Ren, E.C. Detection of integrated hepatitis B virus DNA in hepatocellular carcinoma cell lines by nonradioactive in situ hybridization. J. Med. Virol. 1990, 30, 266-271. (Pubitemid 20203829)
23. Jemmerson, R.; LaPlante, B.; Treeful, A. Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. Cell Death Differ. 2002, 9, 538-548. (Pubitemid 34521181)